Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Jauset

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Opinion in Pharmacology|May 4, 2019
Bioactive cell penetrating peptides and proteins in cancer: a bright future aheadToni Jauset, Marie-Eve Beaulieu
Oncoscience|August 5, 2016
Ibrutinib repurposing: from B-cell malignancies to solid tumorsDaniel Massó-Vallés, Toni Jauset, Laura Soucek
Oncotarget|April 23, 2016
Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivationFrancesco Paolo Fiorentino, Elvan Tokgün, Sònia Solé-Sánchez, et al.
Oncotarget|May 4, 2018
BET inhibition is an effective approach against KRAS-driven PDAC and NSCLCToni Jauset, Daniel Massó-Vallés, Sandra Martínez-Martín, et al.
Cancer Research|April 17, 2015
Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinomaDaniel Massó-Vallés, Toni Jauset, Erika Serrano, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 28, 2019
Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion BodiesMireia Pesarrodona, Toni Jauset, Zamira V Díaz-Riascos, et al.
Genes & Development|September 2, 2025
Corrigendum: Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Genes & Development|April 6, 2023
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Life Science Alliance|March 3, 2021
The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic isletsMariano F Zacarías-Fluck, Toni Jauset, Sandra Martínez-Martín, et al.
Nature Communications|August 19, 2014
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosisDaniela Annibali, Jonathan R Whitfield, Emilia Favuzzi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|May 4, 2019
Bioactive cell penetrating peptides and proteins in cancer: a bright future aheadToni Jauset, Marie-Eve Beaulieu
Oncoscience|August 5, 2016
Ibrutinib repurposing: from B-cell malignancies to solid tumorsDaniel Massó-Vallés, Toni Jauset, Laura Soucek
Oncotarget|April 23, 2016
Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivationFrancesco Paolo Fiorentino, Elvan Tokgün, Sònia Solé-Sánchez, et al.
Oncotarget|May 4, 2018
BET inhibition is an effective approach against KRAS-driven PDAC and NSCLCToni Jauset, Daniel Massó-Vallés, Sandra Martínez-Martín, et al.
Cancer Research|April 17, 2015
Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinomaDaniel Massó-Vallés, Toni Jauset, Erika Serrano, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 28, 2019
Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion BodiesMireia Pesarrodona, Toni Jauset, Zamira V Díaz-Riascos, et al.
Genes & Development|September 2, 2025
Corrigendum: Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Genes & Development|April 6, 2023
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanomaMariano F Zacarías-Fluck, Daniel Massó-Vallés, Fabio Giuntini, et al.
Life Science Alliance|March 3, 2021
The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic isletsMariano F Zacarías-Fluck, Toni Jauset, Sandra Martínez-Martín, et al.
Nature Communications|August 19, 2014
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosisDaniela Annibali, Jonathan R Whitfield, Emilia Favuzzi, et al.
Pageof 2